BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10574161)

  • 1. Role of somatostatin analogue-based therapy in unresponsive malignant thymomas.
    Palmieri G; Lastoria S; Montella L; Martignetti A; Lombardi G; Salvatore M; Bianco AR
    Ann Med; 1999 Oct; 31 Suppl 2():80-5. PubMed ID: 10574161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thymoma and somatostatin analogs. Biology, diagnostic and clinical practice].
    Palmieri G; Montella L; Lastoria S
    Minerva Endocrinol; 2001 Sep; 26(3):193-5. PubMed ID: 11753243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin analogs and prednisone in advanced refractory thymic tumors.
    Palmieri G; Montella L; Martignetti A; Muto P; Di Vizio D; De Chiara A; Lastoria S
    Cancer; 2002 Mar; 94(5):1414-20. PubMed ID: 11920496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone.
    Palmieri G; Lastoria S; Colao A; Vergara E; Varrella P; Biondi E; Selleri C; Catalano L; Lombardi G; Bianco AR; Salvatore M
    N Engl J Med; 1997 Jan; 336(4):263-5. PubMed ID: 8995089
    [No Abstract]   [Full Text] [Related]  

  • 5. Polymyositis with respiratory muscle weakness requiring mechanical ventilation in a patient with metastatic thymoma treated with octreotide.
    Rini BI; Gajewski TF
    Ann Oncol; 1999 Aug; 10(8):973-9. PubMed ID: 10509161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial.
    Loehrer PJ; Wang W; Johnson DH; Aisner SC; Ettinger DS;
    J Clin Oncol; 2004 Jan; 22(2):293-9. PubMed ID: 14722038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced pediatric inoperable thymus carcinoma (type C thymoma): case report on a novel therapeutic approach.
    Kertesz GP; Hauser P; Varga P; Dabasi G; Schuler D; Garami M
    J Pediatr Hematol Oncol; 2007 Nov; 29(11):774-5. PubMed ID: 17984697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study.
    Kirzinger L; Boy S; Marienhagen J; Schuierer G; Neu R; Ried M; Hofmann HS; Wiebe K; Ströbel P; May C; Kleylein-Sohn J; Baierlein C; Bogdahn U; Marx A; Schalke B
    PLoS One; 2016; 11(12):e0168215. PubMed ID: 27992479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory recurrent thymoma successfully treated with long-acting somatostatin analogue and prednisolone.
    Ito J; Sekiya M; Miura K; Yoshimi K; Suzuki T; Seyama K; Izumi H; Uekusa T; Takahashi K
    Intern Med; 2009; 48(12):1061-4. PubMed ID: 19525599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.
    Lastoria S; Vergara E; Palmieri G; Acampa W; Varrella P; Caracò C; Bianco RA; Muto P; Salvatore M
    J Nucl Med; 1998 Apr; 39(4):634-9. PubMed ID: 9544670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma.
    Lin K; Nguyen BD; Ettinger DS; Chin BB
    Clin Nucl Med; 1999 Jan; 24(1):24-8. PubMed ID: 9890489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current role of 111In-DTPA-octreotide scintigraphy in diagnosis of thymic masses.
    Guidoccio F; Grosso M; Maccauro M; Orsini F; Perri M; Boni G; Banti E; Grassetto G; Rubello D; Mariani G; Volterrani D
    Tumori; 2011; 97(2):191-5. PubMed ID: 21617714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant thymoma: current status and future directions.
    Lara PN
    Cancer Treat Rev; 2000 Apr; 26(2):127-31. PubMed ID: 10772969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional imaging of thymic disorders.
    Lastoria S; Palmieri G; Muto P; Lombardi G
    Ann Med; 1999 Oct; 31 Suppl 2():63-9. PubMed ID: 10574158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of somatostatin analogues in the treatment of advanced malignant thymomas: case report and review of the literature.
    Pettit L; El-Modir A
    Br J Radiol; 2011 Jan; 84(997):e7-e10. PubMed ID: 21172961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of chemotherapy in malignant thymoma.
    Valente M; Schinzari G; Ricciotti A; Barone C
    Ann Ital Chir; 2007; 78(5):377-80. PubMed ID: 18338542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptor scintigraphy in thymoma imaging method and clinical application.
    Marienhagen J; Schalke B; Aebert H; Held P; Eilles C; Bogdahn U
    Pathol Res Pract; 1999; 195(8):575-81. PubMed ID: 10483589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymoma.
    Morgenthaler TI; Brown LR; Colby TV; Harper CM; Coles DT
    Mayo Clin Proc; 1993 Nov; 68(11):1110-23. PubMed ID: 8231276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thymoma associated with pure red cell aplasia and Kaposi's sarcoma].
    Ketata W; Fouzi S; Msaad S; Ben Amira S; Yangui I; Ayoub A
    Rev Mal Respir; 2009 Jan; 26(1):78-82. PubMed ID: 19212295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of malignant thymoma. Case report and review of the literature.
    Hu E; Levine J
    Cancer; 1986 Mar; 57(6):1101-4. PubMed ID: 3080220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.